α-Tocopherol regulates ectonucleotidase activities in synaptosomes from rats fed a high-fat diet

Cell Biochemistry and Function

Volumn 30, Issue 4, 2012, Pages 286-292

  Gutierres, Jessié Martins ^a   Kaizer, Rosilene Rodrigues ^a   Schmatz, Roberta ^a   Mazzanti, Cinthia Melazzo ^a   Vieira, Juliano Marchi ^a   Rodrigues, Marília Valvassori ^a   Jaques, Jeandre ^a   Carvalho, Fabiano ^a   Zanini, Daniela ^a   Morsch, Vera Maria ^a   Schetinger, Maria Rosa Chitolina ^a   Spanevello, Roselia Maria ^b  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

tocopherol; Ectonucleotidases; High fat diets; Rats; Synaptosomes

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; ECTO 5' NUCLEOTIDASE; ECTONUCLEOTIDASE; NUCLEOTIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN PROTECTION; BRAIN SYNAPTOSOME; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; EUTHANASIA; HIPPOCAMPUS; HYDROLYSIS; LIPID DIET; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; CEREBRAL CORTEX; CORPUS STRIATUM; DIET, HIGH-FAT; HIPPOCAMPUS; HYDROLYSIS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC; SYNAPTOSOMES;

ANIMALIA; RATTUS;

EID: 84861930810     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2797     Document Type: Article

References (48)

1. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature 2004; 639: 430-631.
2. Greenwood C, Winocur G. Studies of the effects of high fat diets on cognitive function in a rat model. Neurobiol Aging 2005; 26: 46-49.
3. Hooijmans CR, Kiliaan AJ. Fatty acids, lipid metabolism and Alzheimer pathology. Eur J Pharmacol 2008; 585: 176-196.
4. Luchsinger JA, Tang M, Shea S, Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch Neurol 2002; 59: 1258-1263.
5. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N. Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 2003; 60: 194-200.
6. Parrott MD, Greenwood CE. Dietary influences on cognitive function with aging: from high-fat diets to healthful eating. Ann N Y Acad Sci 2007; 1114: 389-397.
7. Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 2000; 7: 321-331.
8. Canevari L, Clark JB. Alzheimer's disease and cholesterol: the fat connection. Neurochem Res 2007; 32: 739-750.
9. Winocur G, Greenwood C. The effects of high fat diets and environmental influences on cognitive performance in rats. Behav Brain Res 1999; 101: 153-161.
10. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 2006; 112: 358-404.
11. Zimmermann H. Two novel families of ectonucleotidases: molecular structure, catalytic properties and a search for function. Trends Pharmacol Sci 1999; 20: 231-236.
12. Zimmermann H. Nucleotide signaling in nervous system development. Arch Eur J Physiol 2006; 452: 573-588.
13. Schetinger MRC, Vieira VL, Morsch VM, Balz D. ATP and ADP hydrolysis in fish, chicken and rat synaptosomes. Comp Biochem Physiol 2001; 128: 731-741.
14. Schetinger MRC, Morsch VM, Bonan CD, Wyse A. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health. Biofactors 2007; 31: 77-98.
15. Atkinson J, Epand R. Tocopherols and tocotrienols in membranes: a critical review. Free Radic Biol Med 2008; 44: 739-764.
16. Bianchini R, Penteado MVC. Vitamin E. In Vitamins: Nutritional, Biochemical, Clinical and Analytical aspects. Manole: Barueri, 2003; 23-164.
17. Ball GFM. Vitamin E. In Bioavailability and analysis of vitamin in foods. Chapman & Hall: London, 1998; 195-239.
18. Meydani M. Vitamin E. Lancet 1995; 345: 170-175.
19. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17: 24-38.
20. Martin A, Janigian D, Shukitt-Hate B, Prior RL, Joseph JA. Effect of vitamin E intake on levels of vitamins E and C in the central nervous system and peripheral tissues: implications for health recommendations. Brain Res 1999; 845: 50-59.
21. Devi AS, Prathima S, Subramanyam MVV. Dietary vitamin E and physical exercise: I. Altered endurance capacity and plasma lipid profile in ageing rats. Exp Gerontol 2003; 38: 285-290.
22. Devi AS, Kiran TR. Regional responses in antioxidant system to exercise training and dietary Vitamin E in aging rat brain. Neurobiol Aging 2004; 25: 501-508.
23. Ceriello A, Motz E. Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited. Art Thromb Vasc Biol 2004; 24: 816-823.
24. Kaizer RR, da Silva AC, Corrêa MC, Schetinger MRC. Diet-induced changes in AChE activity after long-term exposure. Neurochem Res 2004; 29: 2251-2255.
25. Nagy A, Delgado-Escueta AV. Rapid preparation of synaptosomes from mammalian brain using nontoxic isosmotic gradient material (Percoll). J Neurochem 1984; 43: 1114-1123.
26. Schetinger MRC, Porto NM, Moretto MB, Morsch VM, Rocha JBT, Vieira V. New benzodiazepines alter acetylcholinesterase and ATPDase activities. Neuroch Res 2000; 25: 949-955.
27. Heymann D, Reddington M, Kreutzberg GM. Subcellular localization of 5'-nucleotidase in rat brain. J Neurochem 1984; 43: 263-273.
28. Chan K, Delfert D, Junger KD. A direct colorimetric assay for Ca2+-ATPase activity. Anal Biochem 1986; 157: 375-378.
29. Bradford MM. A rapid and sensitive method for the quantification of Microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 218-254.
30. Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra GM, Manjon M. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 2003; 61: 199-205.
31. Samuel W, Masliah E, Hill LR, Butters N, Terry R. Hippocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology 1994; 44: 2081-2088.
32. Marshansky VN, Norgorodov SA, Yaguzhinsky LS. The role of lipid peroxidation in the induction of cation transport in rat liver mitochondria. The antioxidant effect of oligomycin and dicyclohexylcarbodiimide. FEBS Lett 1983; 158: 27-30.
33. Palmeira CM, Oliveira CR. Partitioning and membrane disordering effects of dopamine antagonists: influence of lipid peroxidation, temperature, and drug concentration. Arch Biochem Biophys 1992; 295: 161-171.
34. i increase during oxidative stress. Brain Res 1996; 713: 269-277.
35. Santos MS, Duarte AI, Matos MJ, Proença T, Seiça R, Oliveira CR. Synaptosomes isolated from Goto-Kakizaki diabetic rat brain exhibit increased resistance to oxidative stress: role of vitamin E. Life Sci 2000; 67: 3061-3073.
36. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 2006; 27: 166-176.
37. Robson S, Sévigny J, Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2006; 2: 409-430.
38. Cunha RA. Adenosine as a neuromodulador and as homeostasis regulator in nervous system: different role, different sources and different receptors. Neurochem Intern 2001; 38: 107-125.
39. Cunha RA. Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade. Purinergic Signal 2005; 1: 111-34.
40. Svenningsson P, Nomikos GG, Fredholm BB. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J Neurosci 1999; 19: 4011-4022.
41. Deckert J, Abel F, Kunig G, et al. Loss of human hippocampal adenosine A1 receptors in dementia: evidence for lack of specificity. Neurosci Lett 1998; 244: 1-4.
42. Jeon S, Yong P, Kwon O, et al. Vitamin E supplementation alters HDL cholesterol concentration and paraoxonase activity in rabbits fed high cholesterol diet: comparasion with probucol. J Biochem Mol Toxicol 2005; 19: 336-346.
43. Upston JM, Terentis AC, Stocker R. Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J 2008; 13: 977-994.
44. The Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1993; 328: 176-183.
45. Pappert EJ, Tangney CC, Goetz CG, et al. Alpha tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: Dose response study and correlation with plasma levels. Neurology 1996; 47: 1037-1042.
46. Cadet JL, Katz M, Jackson-Lewis V, Fahn S. Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Brain Res 1989; 476: 10-15.
47. Nishida Y, Yokota T, Takahashi T, et al. Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem Biophys Res 2006; 350: 530-536.
48. Spanevello RM, Mazzanti CM, Schmatz R, Bagatini M, Stefanello N, Correa MC. Effect of vitamin E on ectonucleotidase activities in synaptossomes and platelets and parameters of oxidative stress in rats experimentally demyelinated. Brain Res Bull 2009; 80: 45-51.